Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Vyxeos

(VIK-see-os)
A form of the anticancer drugs daunorubicin hydrochloride and cytarabine that is contained inside very tiny, fat-like particles and is used to treat adults with certain types of newly diagnosed acute myeloid leukemia. Vyxeos may have fewer side effects and work better than other forms of these drugs. It is also being studied in the treatment of other types of cancer. Vyxeos is a type of anthracycline antibiotic, a type of topoisomerase inhibitor, and a type of antimetabolite. Also called daunorubicin hydrochloride and cytarabine liposome.
Search NCI's Dictionary of Cancer Terms